CLINICAL TRIALS PROFILE FOR SOMATROPIN [RDNA ORIGIN]
✉ Email this page to a colleague
All Clinical Trials for somatropin [rdna origin]
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00079742 ↗ | A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis | Completed | Genentech, Inc. | Phase 2 | 2003-09-01 | This is a Phase II, multicenter, randomized, controlled, open-label trial of the safety and efficacy of Nutropin AQ administered subcutaneously (SC) daily in prepubertal children with CF and growth restriction. |
| NCT00191113 ↗ | Somatropin Treatment to Final Height in Turner Syndrome | Completed | Eli Lilly and Company | Phase 3 | 1989-02-01 | A randomized, controlled trial in girls with Turner syndrome at least 7 years old and younger than 13 at study entry, to determine the efficacy and safety of Humatrope (somatropin) treatment in promoting linear growth to final height. |
| NCT00191360 ↗ | Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency | Completed | Eli Lilly and Company | Phase 3 | 2003-01-01 | To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for somatropin [rdna origin]
Condition Name
Clinical Trial Locations for somatropin [rdna origin]
Trials by Country
Clinical Trial Progress for somatropin [rdna origin]
Clinical Trial Phase
Clinical Trial Sponsors for somatropin [rdna origin]
Sponsor Name
